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989–99.Disagreement Between Different Deﬁnitions
of Coronary Artery Calcium ProgressionProgression of coronary artery calcium (CAC) as
measured by computed tomography independently
predicts coronary heart disease (CHD) events (1).
Several methods have been proposed to deﬁne and
quantify CAC progression yet very few studies have
compared different CAC progression deﬁnitions
(2,3). We sought to determine the concor-
dance between different CAC progression deﬁni-
tions and their association with traditional CHD risk
factors.
The Cooper Center Longitudinal study is a cohort
of >100,000 individuals referred for preventive
medical examination in Dallas, Texas. This report
includes 6,597 individuals (mean age 51.8 years,
22.8% female) who underwent serial cardiac com-
puted tomography scanning (Imatron C-150XP or
C-300, Siemens, Malvern, Pennsylvania) at least
9 months apart between the years of 1998 and
2006 (mean interval 2.9 years). Individuals with
previous CHD or coronary intervention between
scans were excluded. Participants provided informed
consent and the study was approved by the institu-
tional review board of the Cooper Institute. CAC
incidence (development of CAC in individuals with
baseline CAC ¼ 0) and CAC progression (increasing
CAC in individuals with baseline CAC > 0 in Agatston
units [AU]) were analyzed separately. Various pro-
gression deﬁnitions were applied as originally
described (2–4):
1. Continuous progression (annualized):
a. Absolute change: CACfollowup  CACbaseline
b. Log transformed change:
lnðCACfollowup þ 25Þ  lnðCACbaseline þ 25Þ
c. Square root transformed change:
OCACfollowup  OCACbaseline
d. Percentage of change:
½ðCACfollowup  CACbaselineÞ=CACbaseline  1002. Categorical progression:
a. Hokanson method:
ðOCACfollowup  OCACbaselineÞ >2:5
b. Raggi method: ½ðCACfollowup  CACbaselineÞ=
CACbaseline

>15%=year
c. Berry method:
For CAC >0 and # 100 AU:baseline
CACfollowup  CACbaseline

>10 AU=year
For CACbaseline >100 AU: ½ðCACfollowup
 CACbaseline

CACbaseline

>10%=yearprogression was also analyzed according to
only used risk categories (i.e., 0, >0 to <10, 10CAC
comm
to <100, 100 to <400, and $400 AU).
At baseline, 3,336 participants (50.6%) had CAC
scores of 0 and in this group, 520 (15.6%) had a positive
follow-up score. Among those with baseline CAC >0
(n ¼ 3,259), the median annualized change in CAC
was 17.7 AU [interquartile range: 32.4 to 67.8 AU].
Applying categorical methods, the binary classiﬁ-
cation of CAC progression was as follows: 44.2% pro-
gressed by Hokanson (45.7% in men, 33.0% women;
35.0% in baseline CAC <100 AU, 55.0% CAC $100 AU);
57.1% by Raggi (57.1% in men, 57.4% women; 67.8% in
baseline CAC<100 AU, 40.1% CAC$100 AU) and 52.5%
by Berry (53.8% in men, 43.1% women; 44.0% in
baseline CAC <100 AU, 62.3% CAC $100 AU). Cross-
tabulation between the most commonly referenced
methods, Hokanson and Raggi (2,3), revealed modest
concordance (70.5%) with a kappa coefﬁcient of 0.420.
Concordance estimates stratiﬁed by age, sex, and
baseline CAC score were: 70.1% for age #50 years,
70.4% age >50 years; 66.3% in women, 71.1% men;
66.7% for CAC <100 AU, 74.9% CAC $100 AU. When
stratiﬁed by risk categories, 27.9% moved to a higher
risk group, 0.7% moved to a lower risk group, and
71.4% remained in the same group.
Using logistic and linear regression models, the
predictors of CAC progression varied across different
deﬁnitions (Table 1). Notably, the annualized percent-
age of change method did not show consistent asso-
ciation with most well-established predictors of CHD.
The existing CAC progression deﬁnitions are based
on a variety of principles including interscan vari-
ability, observed relative changes from case-control
studies, and arbitrary yet logical constructs, so it is
not surprising that they result in divergent classiﬁca-
tion. There are no formal comparisons between dif-
ferent deﬁnitions of CAC progression related to CHD
events, just all-cause mortality (2). Though our study
is unable to identify a superior method, it does high-
light important limitations of deﬁnitions based on
TABLE 1 Predictors of Coronary Artery Calcium Progression and Incidence Across Different Deﬁnitions
Continuous Progression Methods Categorical Progression Methods Incidence
Absolute Log Square root Percentage Hokanson Raggi Berry Risk Categories* Incidence >0
Age     þ
Male þ þ
Total cholesterol þ þ
HDL-C   
Statin þ þ þ þ þ þ þ þ
SBP þ þ þ þ þ
Hypertension medication þ þ þ þ þ þ þ
Smoking
Fasting glucose þ þ þ þ þ þ
FHCVD þ
BMI
Baseline CAC þ  þ  þ   NA
“þ”¼ positive independent association with a p < 0.05. “–”¼ inverse independent association with a p< 0.05. Empty cells indicate absence of independent association. All models were additionally adjusted
for interscan interval. *Risk categories consist of CAC >0 to <10, 10 to <100, 100 to <400, and $400 AU.
AU ¼ Agatston unit; BMI ¼ body mass index; CAC ¼ coronary artery calcium; FHCVD ¼ family history of cardiovascular disease; HDL-C ¼ high-density lipoprotein cholesterol; NA ¼ not applicable; SBP ¼
systolic blood pressure.
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744relative change, particularly in individuals with low
baseline scores. Small absolute changes corresponding
to large relative differences in those with low baseline
CAC are likely to drive classiﬁcation and result in
incongruent associations with CHD risk factors. In
addition, the Hokanson and Raggi methods had worse
concordance in women than inmen. Thus, inmenwith
higher scores, there may be less dependence on spe-
ciﬁc deﬁnitions to categorize CAC progression.
In conclusion, we demonstrate that different CAC
progression deﬁnitions can result in divergent sub-
ject classiﬁcation in up to 30% of individuals, which
may alter research ﬁndings or impact individualized
clinical decisions. More research is needed to
identify which deﬁnition most closely associates
with CHD outcomes prior to the widespread appli-
cation of CAC progression as a clinical or research
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2009;119:382–9.Value of CMR to Differentiate Cardiac
Angiosarcoma From Cardiac LymphomaPrimary cardiac malignancies are extremely rare (1).
The 2 most common tumors (i.e., angiosarcoma and
lymphoma) are usually right sided and often located
near the right atrial wall and right atrioventricular
groove, hampering differentiation on cardiac imag-
ing. We describe the value of cardiac magnetic reso-
nance (CMR) in 12 patients with these tumors (7
angiosarcomas and 5 cardiac lymphomas [all B cell
non-Hodgkin, HIV negative], all conﬁrmed by biopsy
[n ¼ 11] or autopsy [n ¼ 1]). Patients with
